CRISPR Genomic Cure Market Size to Reach $14.80 Billion, Globally, by 2030 at 34.7% CAGR: Coherent Market Insights (CMI)
27 juil. 2023 05h40 HE
|
CMI
Burlingame, July 27, 2023 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, “Crispr Genomic Cure Market, By Disease Type (Genetic Disorders, Cancer, Infectious Diseases,...
CRISPR Technology Market to Reach US$ 7.72 Billion by 2030: Coherent Market Insights
11 juil. 2023 12h18 HE
|
CMI
Burlingame, July 11, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global CRISPR technology market is generated $2.25 billion in 2022, and is anticipated to generate $7.72 billion...
CRISPR Market: 2023 Research Report by Key Players, Global Demand, Industry Size and Share Estimations, Increasing Opportunity Forecast to 2027
12 juin 2023 05h51 HE
|
Absolute Reports Pvt Ltd
Pune, June 12, 2023 (GLOBE NEWSWIRE) -- Global “CRISPR Market” Growth Research 2023-2027: regional developments and industry segments by type and applications. This 103 Pages Report focuses on...
CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies
22 août 2017 07h30 HE
|
CRISPR Therapeutics AG
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT
08 mai 2017 08h00 HE
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference
30 mars 2017 08h00 HE
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., March 30, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing
28 mars 2017 08h00 HE
|
CRISPR Therapeutics AG
- Patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting, including human and other eukaryotic cells BASEL, Switzerland, March 28, 2017 (GLOBE...
CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte
14 mars 2017 07h00 HE
|
CRISPR Therapeutics AG
BASEL, Switzerland, CAMBRIDGE, Mass., and GAITHERSBURG, Md., March 14, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative...
CRISPR Therapeutics to Present at the Annual Barclays Global Healthcare Conference
02 mars 2017 16h30 HE
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., March 02, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation
28 févr. 2017 08h00 HE
|
CRISPR Therapeutics AG
Experienced leader with extensive experience in immuno-oncologyDedicated unit in immuno-oncology to accelerate efforts BASEL, Switzerland and CAMBRIDGE, Mass., Feb. 28, 2017 (GLOBE NEWSWIRE) --...